NR4A1 and in situ carcinoma: In those previous studies, where the invasive nature of the CMC has not been consistently confirmed by p63 immunohistochemistry, the higher incidence of carcinomas in situ may explain the high level of hormone receptor-positive (luminal) neoplasms.